PRTK Annual Interest Expense
$18.12 M
+$711.00 K+4.08%
31 December 2022
Summary:
As of January 21, 2025, PRTK annual interest expense is $18.12 million, with the most recent change of +$711.00 thousand (+4.08%) on December 31, 2022. During the last 3 years, it has risen by +$1.72 million (+10.46%).PRTK Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Quarterly Interest Expense
$5.29 M
+$811.00 K+18.12%
30 June 2023
Summary:
As of January 21, 2025, PRTK quarterly interest expense is $5.29 million, with the most recent change of +$811.00 thousand (+18.12%) on June 30, 2023. Over the past year, it has increased by +$741.00 thousand (+16.30%).PRTK Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK TTM Interest Expense
$18.86 M
+$741.00 K+4.09%
30 June 2023
Summary:
As of January 21, 2025, PRTK TTM interest expense is $18.86 million, with the most recent change of +$741.00 thousand (+4.09%) on June 30, 2023. Over the past year, it has increased by +$1.08 million (+6.05%).PRTK TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Interest Expense Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +4.1% | +16.3% | +6.0% |
3 y3 years | +10.5% | +6.4% | -0.7% |
5 y5 years | +256.7% | +82.1% | +15.0% |
PRTK Interest Expense High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time | -10.5% | at high | -6.8% |
Paratek Pharmaceuticals Interest Expense History
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2023 | - | $5.29 M(+18.1%) | $18.86 M(+4.1%) |
Mar 2023 | - | $4.48 M(-1.8%) | $18.12 M(-0.0%) |
Dec 2022 | $18.12 M(+4.1%) | $4.56 M(+0.5%) | $18.12 M(+0.9%) |
Sept 2022 | - | $4.54 M(-0.2%) | $17.95 M(+1.0%) |
June 2022 | - | $4.55 M(+1.5%) | $17.78 M(+1.1%) |
Mar 2022 | - | $4.48 M(+2.1%) | $17.58 M(+1.0%) |
Dec 2021 | $17.41 M(-14.0%) | $4.39 M(+0.5%) | $17.41 M(-4.8%) |
Sept 2021 | - | $4.37 M(+0.5%) | $18.28 M(-4.2%) |
June 2021 | - | $4.34 M(+0.9%) | $19.09 M(-3.2%) |
Mar 2021 | - | $4.31 M(-18.2%) | $19.72 M(-2.6%) |
Dec 2020 | $20.24 M(+23.4%) | $5.27 M(+1.7%) | $20.24 M(+3.3%) |
Sept 2020 | - | $5.18 M(+4.2%) | $19.60 M(+3.3%) |
June 2020 | - | $4.97 M(+3.0%) | $18.98 M(+5.4%) |
Mar 2020 | - | $4.83 M(+4.3%) | $18.00 M(+9.8%) |
Dec 2019 | $16.40 M(+49.3%) | $4.63 M(+1.4%) | $16.40 M(+9.6%) |
Sept 2019 | - | $4.56 M(+14.3%) | $14.97 M(+8.5%) |
June 2019 | - | $3.99 M(+23.7%) | $13.79 M(+8.6%) |
Mar 2019 | - | $3.23 M(+1.1%) | $12.71 M(+15.6%) |
Dec 2018 | $10.98 M | $3.19 M(-5.6%) | $10.99 M(+19.3%) |
Sept 2018 | - | $3.38 M(+16.5%) | $9.21 M(+27.3%) |
June 2018 | - | $2.90 M(+92.7%) | $7.23 M(+32.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2018 | - | $1.51 M(+6.7%) | $5.45 M(+7.4%) |
Dec 2017 | $5.08 M(+57.6%) | $1.41 M(+0.4%) | $5.08 M(+12.3%) |
Sept 2017 | - | $1.41 M(+25.0%) | $4.52 M(+15.0%) |
June 2017 | - | $1.13 M(-0.5%) | $3.93 M(+8.5%) |
Mar 2017 | - | $1.13 M(+32.4%) | $3.63 M(+12.5%) |
Dec 2016 | $3.22 M(+318.6%) | $855.00 K(+4.3%) | $3.22 M(+5.2%) |
Sept 2016 | - | $820.00 K(+0.2%) | $3.06 M(+33.7%) |
June 2016 | - | $818.00 K(+12.1%) | $2.29 M(+52.9%) |
Mar 2016 | - | $730.00 K(+4.7%) | $1.50 M(+94.9%) |
Dec 2015 | $770.00 K(+7.2%) | $697.00 K(+1383.0%) | $769.00 K(+968.1%) |
Sept 2015 | - | $47.00 K(+88.0%) | $72.00 K(+188.0%) |
June 2015 | - | $25.00 K(>+9900.0%) | $25.00 K(>+9900.0%) |
Mar 2015 | - | $0.00(-100.0%) | $0.00(-100.0%) |
Dec 2014 | $718.00 K(+301.1%) | - | - |
Sept 2010 | - | $3000.00(-25.0%) | $14.00 K(-6.7%) |
June 2010 | - | $4000.00(+33.3%) | $15.00 K(-6.3%) |
Mar 2010 | - | $3000.00(-25.0%) | $16.00 K(-91.1%) |
Dec 2009 | $179.00 K(-76.6%) | $4000.00(0.0%) | $179.00 K(+2.3%) |
Sept 2009 | - | $4000.00(-20.0%) | $175.00 K(+2.3%) |
June 2009 | - | $5000.00(-97.0%) | $171.00 K(+3.0%) |
Mar 2009 | - | $166.00 K | $166.00 K |
Dec 2008 | $766.00 K | - | - |
FAQ
- What is Paratek Pharmaceuticals annual interest expense?
- What is the all time high annual interest expense for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals annual interest expense year-on-year change?
- What is Paratek Pharmaceuticals quarterly interest expense?
- What is the all time high quarterly interest expense for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals quarterly interest expense year-on-year change?
- What is Paratek Pharmaceuticals TTM interest expense?
- What is the all time high TTM interest expense for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals TTM interest expense year-on-year change?
What is Paratek Pharmaceuticals annual interest expense?
The current annual interest expense of PRTK is $18.12 M
What is the all time high annual interest expense for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high annual interest expense is $20.24 M
What is Paratek Pharmaceuticals annual interest expense year-on-year change?
Over the past year, PRTK annual interest expense has changed by +$711.00 K (+4.08%)
What is Paratek Pharmaceuticals quarterly interest expense?
The current quarterly interest expense of PRTK is $5.29 M
What is the all time high quarterly interest expense for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high quarterly interest expense is $5.29 M
What is Paratek Pharmaceuticals quarterly interest expense year-on-year change?
Over the past year, PRTK quarterly interest expense has changed by +$741.00 K (+16.30%)
What is Paratek Pharmaceuticals TTM interest expense?
The current TTM interest expense of PRTK is $18.86 M
What is the all time high TTM interest expense for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high TTM interest expense is $20.24 M
What is Paratek Pharmaceuticals TTM interest expense year-on-year change?
Over the past year, PRTK TTM interest expense has changed by +$1.08 M (+6.05%)